NEOsphere Biotechnologies
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- $6.1M
Investors
- 4
About NEOsphere Biotechnologies
Based in Planegg, Germany, and founded in 2022 by Prof Dr. Henrik Daub (CSO) and Dr. Jutta Fritz (CBO), NEOsphere Biotechnologies GmbH develops small molecule degraders as therapeutic agents. The company offers an integrated proteomics platform that helps in developing therapeutic medicine which can eliminate TPD (Targeted protein degradation). Additionally, the firm conducts a deep proteomic screening by exploring degrader targets and degrader chemistries to unlock the therapeutic potential of degrader molecules which in return helps in drug development.
Who invested in NEOsphere Biotechnologies
4 investors across 2 rounds
See all investors in NEOsphere Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NEOsphere Biotechnologies
Who invested in NEOsphere Biotechnologies?
NEOsphere Biotechnologies has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NEOsphere Biotechnologies raised?
NEOsphere Biotechnologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NEOsphere Biotechnologies last raise money?
NEOsphere Biotechnologies's most recent round on record is a Series A, in Sep 2022.
What does NEOsphere Biotechnologies do?
Based in Planegg, Germany, and founded in 2022 by Prof Dr.
Where is NEOsphere Biotechnologies headquartered?
NEOsphere Biotechnologies is headquartered in Germany.
Which VCs invest in companies like NEOsphere Biotechnologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at NEOsphere Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NEOsphere Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.